These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 9823552

  • 1. [Nephropathy and 5-aminosalicylic acid].
    Bonnet J.
    Gastroenterol Clin Biol; 1998; 22(8-9):663-4. PubMed ID: 9823552
    [No Abstract] [Full Text] [Related]

  • 2. Epidemiology of toxic nephropathies.
    Elseviers MM, De Broe ME.
    Adv Nephrol Necker Hosp; 1997; 27():241-62. PubMed ID: 9408450
    [No Abstract] [Full Text] [Related]

  • 3. [Kidney damage in treatment with non-steroidal anti-inflammatory agents].
    Raszeja-Wanic B.
    Pol Tyg Lek; 1988 Apr 11; 43(15):467-70. PubMed ID: 3405877
    [No Abstract] [Full Text] [Related]

  • 4. [Chronic interstitial nephritis induced by 5-aminosalicylic acid: a new case report].
    Laboudi A, Makdassi R, Cordonnier C, Fournier A, Choukroun G.
    Nephrologie; 2002 Apr 11; 23(7):343-7. PubMed ID: 12500420
    [Abstract] [Full Text] [Related]

  • 5. [Renal involvement in patients with chronic inflammatory intestinal disease treated with mesalazine. How to prevent its nephrotoxicity?].
    Bonet J, Vaquero M, Bayés B, Romero R.
    Med Clin (Barc); 1999 Jul 10; 113(5):199. PubMed ID: 10480148
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The metabolism of mesalamine and its possible use in colonic diverticulitis as an anti-inflammatory agent.
    Cohen HD, Das KM.
    J Clin Gastroenterol; 2006 Aug 10; 40 Suppl 3():S150-4. PubMed ID: 16885699
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Minimal-change nephropathy induced by 5-aminosalicylic acid.
    Zorzets Z, Bernheim J.
    Nephrol Dial Transplant; 1996 Jun 10; 11(6):1187-8. PubMed ID: 8966008
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
    Levine DS, Riff DS, Pruitt R, Wruble L, Koval G, Sales D, Bell JK, Johnson LK.
    Am J Gastroenterol; 2002 Jun 10; 97(6):1398-407. PubMed ID: 12094857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.